Fosamax Turns Generic ; Was No. 3 Seller for Merck

Summary


TRENTON At least three generic versions of the popular osteoporosis treatment Fosamax are headed for pharmacy shelves with the expiration of the drug's main patent Wednesday, bringing patients hefty savings.

Two of the biggest makers of generic drugs, Teva Pharmaceutical Industries Ltd. and Barr Pharmaceuticals Inc., said Wednesday they will immediately begin selling generic Fosamax, which is made by Merck & Co.

See the full content of this document

Extract


Fosamax Turns Generic ; Was No. 3 Seller for Merck

Merck is also making a generic version of the drug, to be distributed by Corona, Calif.-based ...

See the full content of this document

Sponsored links




ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

Contents in vLex United States

Explore vLex

For Professionals

For Partners

Company